Patrick Schöffski
@schoffski
Followers
2K
Following
320
Statuses
697
Passionate medical oncologist with experimental + public health agenda heading the Dpt. of General Medical Oncology + Lab. of Exp. Oncology at UZ/KU Leuven (BE)
Leuven, Belgium
Joined March 2018
FORTRESS 2025 coming this week … can’t wait to see all the young sarcomologists and experienced faculty again at the most informal, unconventional and stimulating sarcoma event of the year!
1
2
19
Just rounded up the exhausting selection of our next two candidates from a total 222 (!) applicants for a PhD in the Lab. of Experimental Oncology. Warm welcome to Agathe from France and Paschalina from Greece, we are looking forward working with you soon
0
1
5
Retrospective analysis of the natural course, correlative study on novel molecular targets, development of xenografts and 3D tumoroids and creation of an international think tank, all on the topic of synovial sarcoma: thesis of Lore De Cock!
0
1
8
Yet another PhD on sarcoma from the Laboratory of Experimental Oncology at KU Leuven. Congratulations Lore De Cock PhD from your promotor and copromotor. We are proud of you!
0
1
22
Thanks to our international PhD jury members Judith Bovée (Leiden) and Javier Martin-Broto (Madrid) for being with us in Leuven on the occasion of Lore De Cock’s PhD defense
0
2
5
The Roast of Dr. L. De Cock: succesfull defense of synovial sarcoma PhD thesis at KU Leuven on Sep. 07, 2025. Well done, Lore!
0
1
11
RT @sarcomapatients: 🟡 It’s #WorldCancerDay. Sarcomas are often overlooked because they’re rare—making them harder to detect & treat. That’…
0
7
0
Peer review of manuscripts is a very important aspect of scientific publishing but has become totally perverted in the open access era. Now dubious publishers are sending reviewers lists of articles submitted to a range of journals and ask us to select what we want to review!!!
2
1
6
@AKyriazoglou @breelynwilkyMD I wish the regulators in some European countries would share Prof. Kyriazoglou’s optimistic view on the use of immunotherapy in sarcomas. Nothing available or reimbursed over here years after observing the first responses in selected subtypes
0
0
1
Just updated our in vivo platform of patient-derived xenografts of gastrointestinal stromal tumors. All models fully characterized, available for collaborative research and validated in multiple studies, some translating into clinical trials. Read doi: 10.1242/dmm.052225
0
5
21
RT @IntraMedOnco: Interesantes datos del grupo español donde cerca del 20% de #GIST SDHG tienen alteraciones en la vía Pi3K/mTOR con benefi…
0
3
0
RT @schoffski: According to a press release GSK will acquire IDRx! The acquisition includes IDRX-42 as lead molecule of the Boston-based bi…
0
5
0
According to a press release GSK will acquire IDRx! The acquisition includes IDRX-42 as lead molecule of the Boston-based biopharmaceutical company. Congratulations to the involved teams and good luck with the further development of the important compound for treatment of GIST.
0
5
19
@bvantine1 @CCR_AACR Brian, we have to thank you for making Clinical Cancer Research a journal that is considering to publish many important publications related to sarcoma!
0
0
3
UZ Leuven now accredited as OECI Comprehensive Cancer Center!
1
1
13
@PrJEKurtz In contrast with doxorubicin there is no maximum cumulative lifetime dose for chocolate, or at I am ignoring it successfully over the years
1
1
2